| Pharmaceutical active ingredients: |
| Pheniramine MaleatePhenylpropanolamine HydrochloridePyrilamine Maleate |
| Available forms, composition and doses of Triaminic SR: |
| Tablets, Sustained Release; Oral; Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate |
| Triaminic SR medical category: |
| Human:Antihistamines first generationPropylamine derivativesSympathomimetic (adrenergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR06AB05 - PheniramineR06AC01 - Mepyramine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisSandoz |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Quadra-Hist D | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Phenyltoloxamine Citrate; Pyrilamine Maleate | Ethex |
| Trihist-D | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Phenyltoloxamine Citrate; Pyrilamine Maleate | Cypress Pharmaceutical |
| Triatussic | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pholcodine; Pyrilamine Maleate; Sodium Benzoate; Sulfogaiacol | Novartis |
| Triaminic Drops | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis; Wander |
| Triaminic Oral Infant | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis |
| Triaminic Time Release | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis |
| Triaminicol | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis; Sandoz |
| Tri-P | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Cypress Pharmaceutical |
| Trisulfaminic | Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate; Sulfadiazine; Sulfamerazine; Sulfamethazine | Shepherd Pharmaceuticals |
| Poly-Histine | Pheniramine Maleate; Phenyltoloxamine Citrate; Pyrilamine Maleate | Sanofi-Aventis |